|
TARS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.298990E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.200800E-01 |
| Normal-vs-Stage2 |
3.697200E-01 |
| Normal-vs-Stage3 |
9.365000E-03 |
| Normal-vs-Stage4 |
1.518370E-01 |
| Stage1-vs-Stage2 |
1.483570E-01 |
| Stage1-vs-Stage3 |
1.317370E-01 |
| Stage1-vs-Stage4 |
5.458000E-01 |
| Stage2-vs-Stage3 |
3.504400E-02 |
| Stage2-vs-Stage4 |
9.368400E-02 |
| Stage3-vs-Stage4 |
6.995600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.936500E-02 |
| Normal-vs-AfricanAmerican |
3.116000E-02 |
| Normal-vs-Asian |
5.645200E-01 |
| Caucasian-vs-AfricanAmerican |
5.945600E-01 |
| Caucasian-vs-Asian |
4.118200E-01 |
| AfricanAmerican-vs-Asian |
2.815000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.098000E-02 |
| Normal-vs-Female |
3.682800E-01 |
| Male-vs-Female |
1.083800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.418800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.452200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.718000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.224200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.688400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.106000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.372000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.860800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.067800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.157000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.137400E-01 |
| Classical-VS-Follicular |
1.436770E-01 |
| Classical-VS-Other |
1.763190E-01 |
| Classical-VS-Normal |
1.004190E-01 |
| Tall-VS-Follicular |
1.200000E-01 |
| Tall-VS-Other |
3.411800E-01 |
| Tall-VS-Normal |
1.523840E-01 |
| Follicular-VS-Other |
2.165500E-02 |
| Follicular-VS-Normal |
5.830000E-01 |
| Other-VS-Normal |
5.215200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.185800E-01 |
| Normal-vs-N1 |
1.716240E-02 |
| N0-vs-N1 |
9.446300E-02 |
|
|
